[1]
G. C. S. B. Marcelino, E. L. M. de Miranda, and F. Sebastianes, “Multiple endocrinopathies acquired using a checkpoint inhibitor - Pembrolizumab: A Case Report”, Braz J Case Rep., vol. 5, no. 1, p. bjcr15, Aug. 2024.